Abstract: An electronic device battery holder (“EDBH”) for holding a battery with a positive pole and a negative pole includes at least one deflectable electrically-conductive positive terminal prong with a proximal end configured for fixed electrical connection to a power circuit of an electronic device, a deflectable distal end configured to contact a positive pole of a battery operably inserted into the EDBH, and a deflectable middle portion connecting the proximal end and the distal end. The EDBH also includes at least one compressible electrically-conductive negative terminal prong configured to exert a force on the operably inserted battery, to contact a negative pole of the battery, and for fixed electrical connection to the power circuit of the electronic device. The at least one deflectable electrically-conductive positive terminal prong is configured to deflect during insertion of a battery therein and to exert a compressive securing force on an operably inserted battery.

Abstract: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).

Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable derivatives thereof, useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).